Outcomes of Pelvic Surgery With and Without Anti-incontinence Procedure in Occult Stress Urinary Incontinence Patients (PTOS)

July 15, 2014 updated by: Peking Union Medical College Hospital

Improved Reconstruction Pelvic Surgery With and Without Tension-free Vaginal Tape-obturator in Women With Occult Stress Urinary Incontinence(PTOS): a Randomized Controlled Trial

  1. To evaluate whether a standardized tension-free vaginal tape-obturator(TVT-O) procedure, when added to a planned improved reconstruction pelvic surgery, improves the rate of urinary stress continence in subjects with occult stress incontinence.
  2. Observe the immediate and short-term complications, overall urinary tract function, and other aspects of pelvic health between subjects with and without a TVT-O procedure.

Study Overview

Detailed Description

The primary aim of this randomized study is evaluate whether a standardized TVT-O procedure, when added to a planned improved reconstruction pelvic surgery for the treatment of pelvic organ prolapse, improves the rate of urinary stress continence in subjects with occult stress incontinence. Secondary aims include comparison of immediate and short-term complications, overall urinary tract function, and other aspects of pelvic health between subjects with and without a TVT-O procedure. The value of preoperative urodynamic testing with prolapse reduction and 1 hour pad test will also be compared between subjects with and without a concomitant TVT-O procedure.

Study Type

Interventional

Enrollment (Anticipated)

196

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Beijing
      • Beijing, Beijing, China, 100730
        • Obstetrics and Gynecology Department, Peking Union Medical College Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

55 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • In the absence of medical contraindications for improved pelvic floor reconstruction surgery and the TVT-O surgery
  • Bulge of paries anterior vaginas stage III-IV
  • Uterine prolapse stage II-II
  • Without symptoms of stress urinary incontinence
  • Screening tests of occult stress urinary incontinence(OSUI) should be positive
  • ≥55 years old.

Exclusion Criteria:

  • Pregnancy
  • Illegible to follow up after surgery
  • Previous surgery for stress urinary incontinence
  • Unfinished data collection before surgery

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: No TVT-O
Improved reconstruction pelvic surgery
Repair of severe pelvic organ prolapse with mesh.
Experimental: Combined surgery group
Improved reconstruction pelvic surgery TVT-O procedure
Repair of severe pelvic organ prolapse with mesh.
Artificial mesh belt is placed in the middle urethra to provide support to remain no leak

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Stress incontinence
Time Frame: 3 months to 2 years post-operation
Urine loss from physical activity such as coughing, sneezing or laughing.
3 months to 2 years post-operation

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Immediate and short-term complications
Time Frame: Intraoperative and 2 years post-opeartion
Immediate and short-term complications such as hemorrhage, bladder perforation and infection.
Intraoperative and 2 years post-opeartion
Overall urinary tract function
Time Frame: 3 months, 12 months and 2 years post-operation
Overall urinary tract function: two validated questionnaires, standardized POP-Q measurements, urodynamic testing with prolapse reduction and 1 hour pad test.
3 months, 12 months and 2 years post-operation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Lan Zhu, MD, Peking Union Medical College Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2014

Primary Completion (Anticipated)

January 1, 2016

Study Completion (Anticipated)

January 1, 2017

Study Registration Dates

First Submitted

June 19, 2014

First Submitted That Met QC Criteria

July 15, 2014

First Posted (Estimate)

July 17, 2014

Study Record Updates

Last Update Posted (Estimate)

July 17, 2014

Last Update Submitted That Met QC Criteria

July 15, 2014

Last Verified

July 1, 2014

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pelvic Organ Prolapse

Clinical Trials on Improved reconstruction pelvic surgery

Subscribe